• Myelodysplastic Syndromes
• Acute Lymphocytic Leukemia
• Multiple Myeloma

Dr. Bejanyan is a Senior Member, Program Leader of Blood and Marrow Transplant (BMT) and Head of the Leukemia/Myeloid Section of the BMT and Cellular Immunotherapy Department at Moffitt Cancer Center. She is an Associate Professor in Oncologic Sciences at the University of South Florida. Dr. Bejanyan also served as the Clinical Scientific Co-Director of Moffitt Pharmacokinetics and Pharmacodynamics Core.As a physician investigator with clinical and research expertise in BMT and cellular immunotherapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), Dr. Bejanyan focuses in advancing clinical and translational research by fostering innovative immune cell therapy strategies to treat leukemia. She serves as a principal investigator (PI) and Co-PI of several cellular immunotherapy clinical trials in AML, including highly innovative first-in-human clinical trial with donor-derived, expanded anticancer gamma delta T cells to treat high-risk AML after BMT, which was awarded funding from the Florida State Bankhead-Coley grant.Dr. Bejanyan serves as a Co-chair of the Acute Leukemia Working Committee of the Center of International Blood and Marrow Transplant Research (CIBMTR) and as a member of the International Expert Panel for AML Relapse Committee, ASTCT MDS Expert Panel Committee, BMT CTN Steering Committee, BMT CTN State of the Science Symposium Myeloid Malignancy Committee, and the CIBMTR Proposal Task Force.